İrkeç, C. Et Al. 2022. Decreased levels of soluble fractalkine as an early biomarker distinguishing secondary progressive from relapsing remitting multiple sclerosis.. 4th International Turkic World Congress of Multiple Sclerosis, Abstracts and Full Texts Book , vol.4 , 24-26.

İrkeç, C., Kuz, T., & Fidan, I., (2022). Decreased levels of soluble fractalkine as an early biomarker distinguishing secondary progressive from relapsing remitting multiple sclerosis.. 4th International Turkic World Congress of Multiple Sclerosis, Abstracts and Full Texts Book , vol.4, 24-26.

İrkeç, CEYLA, Tuba Kuz, And Isıl Fidan. "Decreased levels of soluble fractalkine as an early biomarker distinguishing secondary progressive from relapsing remitting multiple sclerosis.," 4th International Turkic World Congress of Multiple Sclerosis, Abstracts and Full Texts Book , vol.4, 24-26, 2022

İrkeç, CEYLA Et Al. "Decreased levels of soluble fractalkine as an early biomarker distinguishing secondary progressive from relapsing remitting multiple sclerosis.." 4th International Turkic World Congress of Multiple Sclerosis, Abstracts and Full Texts Book , vol.4, pp.24-26, 2022

İrkeç, C. Kuz, T. And Fidan, I. (2022) . "Decreased levels of soluble fractalkine as an early biomarker distinguishing secondary progressive from relapsing remitting multiple sclerosis.." 4th International Turkic World Congress of Multiple Sclerosis, Abstracts and Full Texts Book , vol.4, pp.24-26.

@article{article, author={CEYLA İRKEÇ Et Al. }, title={Decreased levels of soluble fractalkine as an early biomarker distinguishing secondary progressive from relapsing remitting multiple sclerosis.}, journal={4th International Turkic World Congress of Multiple Sclerosis, Abstracts and Full Texts Book}, year=2022, pages={24-26} }